Analyst consensus rating
BrightSpring Health Services Analyst Rating: Strong Buy
BTSG is rated Strong Buy by 16 analysts with a $78.50 target. As of 2026-08-31.
Direct answer
BrightSpring Health Services's consensus rating is Strong Buy.
16 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $78.50.
Forecast evidence checked August 31, 2026.
Get free BrightSpring Health Services email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $59.13
- Average price target
- $78.50
- High price target
- $90.00
- Low price target
- $70.00
- Low target gap
- +18.4%
- Target upside
- +32.8%
- High target gap
- +52.2%
- Target range width
- 33.8%
- Consensus rating
- Strong Buy
- Analysts
- 16
- Evidence date
- August 31, 2026
- Valid through
- September 7, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for BrightSpring Health Services?
BrightSpring Health Services has a verified Strong Buy consensus. The same dataset has an average price target of $78.50.
How far are BrightSpring Health Services's low and high targets from the recorded price?
The low target implies +18.4%, while the high target implies +52.2%.
How many analysts are included in BrightSpring Health Services's consensus?
The verified consensus includes 16 analysts.
How is BrightSpring Health Services's target upside or downside calculated?
The average target of $78.50 is divided by the recorded price of $59.13, then one is subtracted to produce +32.8%. This does not guarantee a future return.
When was BrightSpring Health Services's analyst forecast verified?
The data was verified on 2026-08-31. The dataset is valid through 2026-09-07.